The molecular and clinical events, including amyloid accumulation, neuroinflammation, tau accumulation, neural degeneration, cognitive decline, and occurrence of behavioral psychological symptoms, develop along with AD progression. The gene discussed is MAPT; the disease is Alzheimer disease.